A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2,2′-dithiobisbenzamides
Authors:
- 1 March 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 5 (3) , 569-579
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDSScience, 1995
- Nonpolarized Distribution of Glycosylphosphatidylinositols in the Plasma Membrane of Polarized Madin-Darby Canine Kidney CellsJournal of Biological Chemistry, 1995
- Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination TherapyScience, 1995
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995
- Analysis of the nucleic acid annealing activites of nucleocapsid protein from HIV-1Nucleic Acids Research, 1995
- Recombinant HIV-1 Nucleocapsid Protein Accelerates HIV-1 Reverse Transcriptase Catalyzed DNA Strand Transfer Reactions and Modulates RNase H ActivityBiochemistry, 1994
- Risking Everything? Risk Behavior, Behavior Change, and AIDSScience, 1994
- Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMRJournal of Molecular Biology, 1994
- Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1Protein Science, 1992
- Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibitionAntimicrobial Agents and Chemotherapy, 1992